1. Home
  2. WNEB vs PROF Comparison

WNEB vs PROF Comparison

Compare WNEB & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western New England Bancorp Inc.

WNEB

Western New England Bancorp Inc.

HOLD

Current Price

$13.70

Market Cap

264.8M

Sector

Finance

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

N/A

Current Price

$6.80

Market Cap

243.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WNEB
PROF
Founded
1853
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.8M
243.2M
IPO Year
2001
2017

Fundamental Metrics

Financial Performance
Metric
WNEB
PROF
Price
$13.70
$6.80
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$13.67
$12.00
AVG Volume (30 Days)
30.6K
54.5K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
2.00%
N/A
EPS Growth
33.93
25.89
EPS
0.24
0.19
Revenue
$44,000.00
$16,098,000.00
Revenue This Year
N/A
$92.40
Revenue Next Year
$7.25
$64.10
P/E Ratio
$56.54
$35.89
Revenue Growth
N/A
50.73
52 Week Low
$8.53
$3.92
52 Week High
$14.52
$8.95

Technical Indicators

Market Signals
Indicator
WNEB
PROF
Relative Strength Index (RSI) 57.53 48.69
Support Level $13.60 $6.47
Resistance Level $14.22 $7.07
Average True Range (ATR) 0.47 0.29
MACD 0.05 -0.02
Stochastic Oscillator 89.05 46.20

Price Performance

Historical Comparison
WNEB
PROF

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.

Share on Social Networks: